Wechselwirkungen · Xromi
Xromi 100 mg/ml oral solution · Abschnitt 4.5 · PDF-Seite 6
HOS-290934 · Präparat HOS-287424
Vaccinations There is an increased risk of severe or fatal infections with the concomitant use of live vaccines. Live vaccines are not recommended in immunosuppressed patients. Concomitant use of hydroxycarbamide with a live virus vaccine may potentiate the replication of the vaccine virus and/or may increase the adverse reaction of the vaccine virus, because normal defence mechanisms may be suppressed by hydroxycarbamide therapy. Vaccination with a live vaccine in a patient taking hydroxycarbamide may result in severe infections. Generally, the patient's antibody response to vaccines may be decreased. Treatment with hydroxycarbamide and concomitant immunisation with live virus vaccines should only be performed if benefits clearly outweigh potential risks (see section 4.4).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-04-28T16:42:00Z · SHA-256 c8829caf21086629d68cab0b5426eba765f2ddc2e2da1cb187e8eb1d478f0a1d · Passage 2a3e791bf8117ec43464469ea18465f7cf1e85218d63a5e9c5e8d6360e830ea0 · Zeichen 1754–2538 im Abschnitt